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NOVEL STRUCTURAL DETERMINANTS OF  THE 
HUMAN NEUTROPHIL  CHEMOTACTIC  
ACT IV ITY  OF  LEUKOTRIENE B* 
BY EDWARD J. GOETZL AND WALTER C. PICKE'VI" 
From the Howard Hughes Medical Institute Laborato~ at Harvard Medical School; the Departments of 
Medicine, Harvard Medical School and the Brigham and Women's Hospital, Boston, Massachusetts 
02115; and the Department ofPharmacology, University of Colorado School of Medicine, Denver, 
Colorado 80262 
Leukotrienes are a unique class of potent humoral and cellular mediators that are 
generated by the specific lipoxygenation and subsequent enzymatic onversions of 
arachidonic acid in basophils, mastocytoma cells, polymorphonuclear leukocytes 
(PMN) and mononuclear leukocytes, and human lung tissue (1-6). The structural 
characteristics shared by the leukotriene mediators include three conjugated ouble 
bonds, a 5-hydroxy group, and either a 6-sulfido-cysteine(yl) or 12-hydroxy group. 5- 
hydroxy-6-sulfido-glutathionyl-eicosa-7,9,11,14-tetraenoic acid (leukotriene (34 [or 
LT(34], where the subscript 4 indicates the total number of double bonds) and 5- 
hydroxy-6-sulfido-cysteinyl-glycine-7,9,11,14-tetraenoic acid (LTD4), which are the 
principal active constituents of the slow-reacting substance of anaphylaxis (termed 
SRS-A), constrict pulmonary airways with a potency up to 20,000 times greater than 
that of histamine and alter the tone and permeability of the microvasculature (7). 
5(S),12(R)-di-hydroxy-eicosa-6,8,10(trans/trans/cis),14(cis)-tetraenoic acid, which is 
designated LTB4 (6), is chemotactic and chemokinetic for human and rat PMN and, 
to a lesser extent, mononuclear leukocytes (8-10). The maximal human neutrophil 
chemotactic response licited by LTB4 is similar in magnitude to those evoked by 
synthetic formyl-methionyl peptides or fragments of the fifth component of human 
complement, and the neutrophil chemotactic potency of LTB4 is far greater than that 
of the mono-hydroxy-eicosatetraenoic acids (HETE) derived from arachidonic acid, 
whereas neither LT(34 nor platelet-derived tri-HETE exhibit leukocyte chemotactic 
activity (8). The results of our study indicate that the conformation of the hydroxyl- 
groups and the geometry of the double bonds in the conjugated triene are the critical 
structural determinants of the potency of LTB4 as a neutrophil chemotactic factor. 
Materials and Methods 
Preparation and Purification of Lipoxygenase Products of Arachidonic Acid. Neutrophils that had 
been isolated from venous blood of normal subjects were incubated for 30 rain at 37°(2 at a 
concentration f 5 × 10 7 neutrophils/ml in Hanks' balanced salt solution containing 0.02 M 
Tris-HCll (pH 8), 10/LM indomethacin, 5/zM calcium ionophore A23187, and 0.5 mg/ml of 
arachidonic acid. The HETE were extracted and resolved from both the residual arachidonic 
acid and more polar products by silicic acid column chromatography (6, 8). LTB4 and 5-HETE 
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were purified by reverse-phase high performance liquid chromatography (HPLC) on a C18 
ODS column (Ultrasphere; Ahex Scientific, Inc., Berkeley, Calif.) that was developed isocrati- 
tally at a flow rate of 1 ml/min with methanol:water:glacial acetic acid (78:22:0.01, vol:vol: 
vol). The 5,12-di-HETE and 5,6-di-HETE isomers contained in the eluates of the silicic acid 
column were resolved from LTB4 and mcno-HETE and were partially purified by reverse- 
phase HPLC on Nucleosil C-18, 5/Lm (Machery-Nagel, Dfiren, Federal Republic of Germany) 
for 60 min. The 5,12-di-HETE and the 5,6-di-HETE were purified by rechromatography 
separately on the Nueleosil column utilizing methanol:water:glacial acetic acid (65:35:0.01, 
vol:vol:voi) and methanol:water:glacial ac,etic acid (75:25:0.01, vol:vol:vol), respectively. The 
highly purified LTB4 and di-HETE isomers contained <1% total of the other isomers. 
The chromatographic characteristics of the two 5,6-di-HETE stereoisomers, for which the 
conformation of the hydroxyl-groups and the geometry of the double bonds have not been 
determined, and the two 5,12-di-HETE with 6,8,10(all-trans), 14(cis)-double bonds, termed 
5,12-alt-trans-di-HETE, have been described previously (6). 5,6-di-HETE-a eluted before 5,6- 
di-Hete-b from the second Nucleosil C-18 column. The 5,12-di-HETE were converted into 
dimenthoxycarbonyl derivatives, ubjected to oxidative ozonolysis, and treated with diazo- 
methane, and the products were analyzed by gas chromatography-mass spectrometry to 
determine the configuration of the 5- and 12-hydroxy-groups (6). The triene portion of LTB4 
consists of one cis- and two trans- double bonds, but the position of the cis- bond has not been 
established unequivocally. LTB4 was methylated by reaction with a 500-fold molar excess of 
diazomethane in ethyl ether for 10 min at room temperature and was acetylated in pyridine by 
reaction with a 100-fold molar excess of acetic anhydride for 20 rain at room temperature; both 
procedures were carried out in an argon environment (11, 12). The identity of each of the 
purified products was confirmed by ultraviolet light absorption spectroscopy, infrared spectros- 
copy, and gas chromatography-mass spectrometry; the products were quantified by optical 
density at characteristic wavelengths of maximal absorption (6). 
Assessment of human eutrophil migration. Chemotaxis of human neutrophils of >96% purity 
was assayed by a modification of the Boyden technique using chambers with a 0.2 ml blind- 
end stimulus compartment (Neuro Probe, Inc., Bethesda, Md.) and filters with 3-/~m pores 
(Sartorius, Science Essentials Division of Beckman Instruments, Inc., Wakefield, Mass.) (8, 11, 
12). Chemotactic fragments of the fifth component of human complement (C5) were prepared 
as described (11). The chemotactic responses were expressed as net neutrophils/high-power fi ld 
(hpf) after subtraction of the background level of migration in the absence of a stimulus. In 
studies designed to examine the inhibition of the neutrophil chemotaetic response to LTB4 by 
derivatives of LTB4, the native principle and the derivative were present ogether in the 
chemotactic factor compartment and the response to the derivative alone was subtracted from 
the activity of the mixture. A standard two-sample Student's t-test was used to calculate levels 
of significance. 
Resu l ts  
LTB4 elicited a neutrophi l  chemotactic response that was detectable at a concen- 
trat ion of 0.3 ng /ml  or ~ 10 -9 M and was maximal  at 30 ng /ml  or ~ 10 -7 M (Fig. 1). 
The maximal  neutrophi l  chemotactic response to LTB~ was similar in magnitude to 
those evoked by the chemotact ic fragments of  C5 (56.6 -I- 7.4, mean - SD, n = 4) or 
by 10 -8 M formyl-methionyl- leucyl-phenylalanine (f-M t-Leu-Phe) (60.3 ± 9.2). The 
other d i -HETE examined were significantly less potent than LTB~ as chemotact ic 
stimuli, but at a concentrat ion of  1,000 ng /ml  evoked maximal  chemotact ic responses 
that were not signif icantly different from that seen with LTB4 at 10 ng/ml .  Thus 
LTB4 was ~100-fold more potent than the other d i -HETE,  when compar ing the 
concentrations required to st imulate maximal  chemotactic responses. An analysis of 
the concentrations needed to achieve a response qual to 50% of the maximal  level 
indicated that the ratio of potency of LTB4 to the analogues ranged from 15 for 
stereoisomer a of the 5,6-di -HETE to >100 for 5(S),12(S)-al l -trans-di-HETE. The 
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FIo. 1. Human neutrophil chemotactic activity of derivatives and analogues of leukotriene B4. 
The points and brackets represent the mean 4- SD of the results of eight determinations of activity 
for LTB4, five for acetyl-LTB4 and four for the other factors. The designation "all-trans" refers to 
the geometry of only the conjugated double bonds in the triene portion of the molecule. LTB4 was 
significantly more chemotactic for neutrophils (P < 0.01) than was acetyl-LTB4 at concentrations 
of 0.3-10 ng/ml, 5,6-di-HETE-a t 0.3-30 ng/ml, and the other analogues at 0.3-100 ng/ml. 
5(S),12(R)-all-trans-di-HETE, in which the 5- and 12-hydroxyl groups possess a 
different conformation, was substantially more potent han the isomer with optically 
equivalent 5(S)- and 12(S)-hydroxyl substituents. 
Acetylation of LTB4 decreased the chemotactic activity significantly at concentra- 
tions of 0.3-10 ng/ml, but not at maximally active concentrations, while incubation 
in pyridine alone or methyl esterification had no effect (Fig. 1). In contrast, the results 
of parallel experiments showed that the methyl ester of 5-HETE had significantly less 
neutrophil chemotactic activity than 5-HETE at concentrations of 200-5,000 ng/ml, 
whereas acetyl-5-HETE expressed neutrophil chemotactic activity that ranged from 
75-87%, 78-91%, and 82-94% that of 5-HETE at concentrations of 200, 1,000 and 
5,000 ng/ml, respectively. The presence of minimally chemotactic concentrations of 
acetyl-LTB4 suppressed the chemotactic responses to LTB4 in proportion to the molar 
ratio of the factors (Fig. 2), but had no effect on the responses to chemotactic 
fragments of C5 or to f-Met-Leu-Phe. At an equimolar concentration, acetyl-LTB4 
inhibited by ~50% the chemotactic responses to 1 ng/ml and 4 ng/ml of LTB4. 
Incubation of portions of neutrophils with 4 ng/ml and 10 ng/ml of acetyl-LTB4, 
followed by washing, failed to suppress the subsequent chemotactic response to 1 ng/ 
ml of LTB4 relative to neutrophils preincubated in buffer alone. LTB4-methyl ester 
had only a minimal inhibitory effect that reached 20% at a 10-fold ratio of LTB4- 
methyl ester:LTB4. 
Discussion 
LTB4 elicits a maximal neutrophil chemotactic response and a response that is one- 
half of the maximal level at concentrations o f~ 10 -7 M and ~6 X 10 -9 M, respectively 
(Fig. 1), which are similar in magnitude to those evoked by 4 X 10 -6 M and 4 × 10 -~ 
M 5-HETE (13), and by 1.7 × 10 -s M and 1.3 X 10 -9 M CSa (14). The neutrophil 
chemotactic activity of acetyl-LTB4 is significantly less than that of LTB4 at concen- 
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Fro. 2. Inhibition of the human neutropbil chemotactic response to leukotriene B4 by acetyl- 
leukotriene ]34. The points and brackets represent the mean :1: SD of the results of four assays with 
neutrophils from different subjects. The control chemotactic responses (100%) to 1 ng/ml and 4 ng/ 
ml of LTB4 ranged from 18.4-26.7 and from 33.6-41.9 net neutrophils/hpf, respectively. *, P < 
0.01; and +, P< 0.05. 
trations on the ascending portion of the dose-response curve, whereas the chemotactic 
potency of acetyl-5-HETE and of 5-HETE are similar. Free hydroxyl-group(s) thus 
are critical determinants of the chemotactic potency of LTB4, but are not required for 
the expression of maximal chemotactic activity at higher concentrations. In contrast, 
methylation of the carboxyl group substantially suppressed the chemotactic potency 
and maximal activity of 5-HETE, but had no significant effect on the function of 
LTB4. 
The availability of a series of other highly purified di-HETE, that were generated 
by neutrophils, permitted an analysis of the functional role of the double bonds in the 
conjugated triene of LTB4. The triene of LTB4, as for that of LTC4 and LTD4, consists 
of one cis- and two trans- double bonds, but the positions of the bonds have not been 
established unequivocally for LTB4 (3, 5, 6). The 5(S),12(R)-all-trans-di-HETE 
isomer, which differs from LTB4 only in having a trans-double bond in place of a cis- 
double bond in the triene portion of the molecule (6), is significantly less potent han 
LTB4, but evokes a maximal chemotactic response of similar magnitude (Fig. 1). The 
cis-double bond and the free hydroxyl-group(s) thus appear to be critical determinants 
of the potency of LTB4, but are not required to attain maximal activity unlike the 
free carboxyl-group of 5-HETE. Although the other 5,12-di-HETE and both 5,6-di- 
HETE isomers also were less potent than LTB4, differences in the conformation or 
position of the second hydroxyl-group as well as in the structure of the triene may 
have contributed to the altered function. 
The capacity of minimally chemotactic concentrations of acetyl-LTB4 to inhibit 
selectively the human neutrophil chemotactic response to LTB4 is reminiscent of the 
competitive inhibition of the chemotactic responses to 5-HETE by 5-HETE methyl 
ester (9) and to f-Met-Leu-Phe by several chemotactically inactive peptide analogues 
(15, 16). That the washing of neutrophils that had been preincubated with acetyl- 
LTB4 fully reversed the suppression of the chemotactic response to LTB4 suggests a
competitive mechanism of inhibition. The results of competitive binding studies 
indicate that some inactive peptide analogues inhibit the chemotactic and other 
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activities of f-Met-Leu-Phe by displacing the stimulus from the receptor, but compa- 
rable binding data are not yet available for LTB4 or the mono-HETE. 
Summary  
A specific 5(S),12(R)-dihydroxy-eicosa-6,8,10(trans/trans/cis), 14( -tetraenoic 
acid, designated leukotriene B, is generated by the lipoxygenation and subsequent 
enzymatic hydration of arachidonic acid in a variety of leukocytes. Leukotriene B
elicits a maximal human neutrophil chemotactic response in vitro which is similar in 
magnitude to those evoked by the chemotactic fragment of the fifth component of 
complement, C5a, synthetic formyl-methionyl peptides, and 5-hydroxy-eicosatetra- 
enoic acid (5-HETE). The neutrophil chemotactic potency of purified leukotriene B, 
assessed by the 50% effective concentration of 6 × 10 -9 M~ is equivalent to that of 
C5a, but is up to 100-fold greater than that of 5-HETE and of other natural di-HETE 
isomers. 5 (S), 12 (R)-di-hydroxy-eicosa-6,8,10 (all-trans), 14 (cis)-tetraenoic acid, which 
differs from leukotriene B only in having a trans-double bond in place of a cis-double 
bond in the triene portion of the molecule, and acetyl-leukotriene B are significantly 
less potent neutrophil chemotactic factors than leukotriene B, which indicates that 
both the conjugated ouble bonds and the free hydroxyl-group(s) are functionally 
critical determinants. The capacity of acetyl-leukotriene B to inhibit competitively 
and selectively the human neutrophil chemotactic response to equimolar concentra- 
tions of leukotriene B suggests the existence of a specific subset of receptors for this 
potent lipid mediator. 
Received for publication 2 October 1980 and in revised form 1 November 1980. 
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